Karyopharm Therapeutics | KPTI - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 435.86B 8.73B 2026-08
Abbott USD 158.05B 20.36B 2026-06
Amgen USD 209.65B 14.21B 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
Enanta Pharmaceuticals USD 122M 98M 2024-12
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Incyte USD 26.84B 4.19B 2026-08
J&J USD 611.36B 32.21B 2026-06
Karyopharm Therapeutics USD 221M 95M 2026-08
MacroGenics USD 184M 82M 2026-03
Merck USD 324.18B 6.81B 2026-08
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Pfizer USD 153.17B 14.73B 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Takeda JPY 8.2T 809.7B 2026-06
Tectonic Therapeutic USD 580M 190M 2026-03
TG Therapeutics USD 7.63B 778M 2026-08
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Xencor USD 1.21B 19M 2026-08